A Phase I Study of the Metal Ionophore Clioquinol in Patients With Advanced Hematologic Malignancies
Aaron D. Schimmer(University of Toronto), Mark D. Minden(University Health Network), Joseph Brandwein(Goethe University Frankfurt), Sharon Keays, Karen Yee(University Health Network), Tristan D. Booth, Vikas Gupta(Indian Institute of Technology Kanpur), Marcela Gronda(Ontario Institute for Cancer Research), Suzanne Ackloo, Jian Chen(Jiangsu University), Christine Chen(University Health Network), Andre C. Schuh(University of Toronto), Zezhou Wang(Ontario Institute for Cancer Research), Yulia Jitkova(Ontario Institute for Cancer Research)
Cited by 43
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2011|692
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
|Blood|2013|632
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616